Dear All,
On behalf of the School, I would like to relay the University’s decision announced yesterday (see email below) regarding the use of all research spaces back to pre-Covid capacity. This measure will allow all Covid SOP constraints to be
rescinded, EXCEPT for the continue use of masks at all times in shared spaces (labs, grad offices, etc.) regardless of vaccination status. With this, research spaces such as grad offices will also be allowed to be opened at 100% occupancy. There
will also no longer be a need for any rotating schedules that research groups have implemented for Covid precautions for both labs and grad offices. All research related occupancy signs, along with Covid SOP signs have already been removed from appropriate
rooms.
Please remember that along with all this masks are still required for everyone at all times in shared spaces. In the days to come, new guidance will be issued regarding the use of face masks for non-instructional spaces, once
that is available I shall follow up with an update.
I would like to express appreciation to everyone for their amazing cooperation throughout this pandemic that allowed us to be able to get to this point and that much more closer to a sense of normalcy. We shall keep the momentum going to
the fall semester and beyond.
If you have any questions or concerns, please feel free to contact me. Thank you all for your time.
Sincerely,
Joshua
---
Joshua Gonzalez
Operations Coordinator
(765) 494-4365 |
(765) 494-0805
|
|
|
|
|
|
We are pleased to announce that effective immediately,
research spaces can return to pre-COVID-19 operations, with the exception of the continued use of face masks. This change will enable researchers to return to 100% capacity in their research
spaces. As a result, any layout, scheduling, or other changes implemented to accommodate COVID-19 safety can be rescinded and these components of Research Space SOPs will be unnecessary. In conjunction with this,
IRB approval will no longer require an approved Research Space SOP. However, we ask that you continue to keep your personnel lists updated through the
SOP
portal to facilitate continued tracking of any research COVID-19 cases, particularly as we implement this relaxation of protocols.
This decision has been made with input from the Protect Purdue Leadership Team and the Medical Advisory Team and affects all researchers, regardless of vaccination status. Around this time last year, we were beginning to re-open research spaces and allow researchers
back into their labs under COVID-19 restrictions. Because of your diligence in following the protocols developed in your SOPs, we are thrilled that we are in the position to re-open operations. Thank you for your flexibility, hard work, and dedication during
this time. Should you have any questions, please contact Michelle Dennis at
mlong1@purdue.edu.
Theresa Mayer
Executive Vice President for Research and Partnerships
|
|
|
|
|
|
|
|
You are receiving this email as a member of the Purdue University research community.
Office of the Executive Vice President for Research and Partnerships: www.purdue.edu/research/
Send comments or questions to purdueresearch@purdue.edu.
Purdue University is an equal access, equal opportunity university.
Produced and published by the Executive Vice President for Research and Partnerships office.
Copyright © 2021,
Purdue University, All rights reserved.
|
|
